Compugen (CGEN) Gross Profit (QoQ) (2012 - 2026)
Powered by 
Analysis
Compugen (CGEN) Gross Profit (QoQ) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Compugen | 242.44 Mn | 156.82 Mn | -92,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -126.14% |
| Mar 31, 2026 | -99.45% |
| Dec 31, 2025 | 26,371.37% |
| Sep 30, 2025 | 159.07% |
| Jun 30, 2025 | -251.72% |
| Mar 31, 2025 | -114.57% |
| Dec 31, 2024 | -94.12% |
| Sep 30, 2024 | 162.74% |
| Jun 30, 2024 | 1,026.91% |
| Dec 31, 2016 | -63.27% |
| Sep 30, 2016 | -88.05% |
| Jun 30, 2016 | 3,316.67% |
| Mar 31, 2016 | -99.84% |
| Dec 31, 2015 | 25,889.29% |
| Sep 30, 2015 | -62.67% |
| Jun 30, 2015 | -42.75% |
| Mar 31, 2015 | -97.65% |
| Dec 31, 2014 | 469.60% |
| Sep 30, 2014 | -11.58% |
| Jun 30, 2014 | -19.69% |